IBJNews

Rival's strong results have WellPoint playing catch-up

Back to TopCommentsE-mailPrintBookmark and Share

WellPoint Inc. CEO Angela Braly wouldn’t have half the headaches she’s battling these days if not for UnitedHealth Group Inc.

The giant Minnesota-based rival of Indianapolis-based WellPoint appears to have done just what the doctor ordered leading up to and after the passage of the 2010 federal health care reform act that will transform the health insurance business.

As a result, UnitedHealth has been enjoying healthy profits, growing customer rolls and a rising stock price—things that WellPoint has been unable to match. That tough comparison lies behind some of the investor ire that has boiled over against Braly in the past month.

Braly, 51, is now building up areas of WellPoint where UnitedHealth already excels. That includes the business of serving Medicare and Medicaid recipients, a segment that’s expected to grow rapidly in the coming years, and programs keeping patients healthier and in need of less health care.

wellpoint-factbox.gifBut she has a long way to go. UnitedHealth has taken 10 and in some cases 20 years to assemble the pieces of its business that are now helping it thrive in the post-reform environment, which features smaller profit margins and greater government involvement.

WellPoint designed its business primarily to serve employers and individuals buying insurance with their own money—and it was arguably more successful than anybody at doing that. But now those commercial segments aren’t growing, and employers are pushing back harder than ever on premium rate increases.

“WellPoint has been very, very commercially focused up until now,” said Ana Gupte, an analyst of health insurance companies at Sanford C. Bernstein & Co. in New York. “They’ve taken awhile to diversify.”

Both WellPoint and UnitedHealth issued statements in response to questions for this story, but neither made executives available for comment.

Investors and analysts like Braly’s game plan for the future—even if they feel it was late in being developed. What they don’t like is all the fumbles that keep happening along the way.

WellPoint has mispriced its business three times in the past four years—which is the health insurance equivalent of not holding on to the football. In addition, it has fallen short of its profit forecast in two of the past three quarters.

“We have lower confidence in WLP’s execution after another earnings disappointment,” wrote Morgan Stanley analyst Melissa McGinnis, using WellPoint’s ticker symbol, when she lowered her rating on the company on Aug. 17. “We do not advocate waiting for better execution, given compelling investment opportunities elsewhere.”

It’s not clear that the blame for these mistakes should fall to Braly, other than because she is the CEO. WellPoint is a massive organization, with 38,000 employees operating Blue Cross or Blue Shield health plans in 14 states. The company insures 33.5 million people.

But Braly’s critics blame her for the companywide miscues. In addition, they point to at least two recent moves that fall squarely on her shoulders.

First, after WellPoint unveiled a widely praised deal this summer to buy Virginia-based Amerigroup Corp. for $4.9 billion, it was revealed that Braly raised the offer for the company from $83 per share to $92 per share even though, according to Amerigroup’s narrative of the deal, no other company made a formal competing bid.

“Come on, Angela. Where’s the responsibility to shareholders. You’ve got nobody bidding against you and you got bid up?” said Sheryl Skolnick, a health care analyst at CRT Capital Group LLC in Connecticut.

In Braly’s defense, a shareholder lawsuit indicates there was a competitor to fend off. The suit, filed against Amerigroup’s board of directors, claims that there was another bidder in play talking about—but never formally offering—an even higher price.

Braly, who has been WellPoint’s CEO for five years, also lost credibility with investors and analysts in July after WellPoint missed its profit targets and lowered its full-year profit forecast—just two weeks after affirming them publicly.

And to make matters worse, Braly insisted in a July conference call with investors that WellPoint was the first company to see consumers going in for more surgeries after a three-year slowdown during the recession. But nearly all of WellPoint’s main competitors reported that rise nine months ago, and adjusted their 2012 outlooks accordingly.

“I don’t buy it,” Gupte said of Braly’s explanations, and most other analysts that follow WellPoint say the same.

Harsh words

The string of blunders has many investors calling for Braly’s head.

Royal Capital Management LLC, a hedge fund that owns nearly 839,000 WellPoint shares, called for Braly’s ouster in an Aug. 22 letter obtained by Bloomberg News.

“We believe there is one—and only one—explanation for WellPoint’s underperformance: well-deserved investor antipathy toward Ms. Braly as a result of a regular cadence of managerial blunders that has plagued her term as CEO,” wrote Royal Capital partners Robert Medway and John Lancefield.

Two WellPoint board members have spoken publicly in vigorous defense of Braly—but the unusual fact they did so has only confirmed the intensity of the criticism she faces.

Braly and WellPoint board members have had numerous private meetings with investors and analysts to try to smooth over their concerns.

Skolnick said she has had multiple conversations with investors who either want the CEO of Amerigroup, Jim Carlson, to replace Braly or who are actively looking for qualified candidates they could suggest to the board—either informally or, if that’s unsuccessful, through a formal proposal at WellPoint’s shareholder meeting next year.

“I’d be surprised,” Skolnick said, when asked if Braly will be CEO of WellPoint a year from now. “A lot of things have to go right for her. She has to become a woman of far more substance.”

It’s the kind of situation that UnitedHealth CEO Stephen Hemsley can relate to. He barely survived the investor backlash against UnitedHealth in 2006 after it was revealed that the company had backdated stock options to generate inflated payouts to executives.

Hemsley, who had been president, replaced company founder Dr. Bill McGuire as CEO and began trying to fix the company’s many problems—not the least of which was its troublesome integration that same year with California-based PacifiCare Heath Systems Inc.

UnitedHealth had many assets with which to orchestrate a turnaround, primarily the broad array of IT businesses that McGuire had acquired and successfully integrated. Those include the well-known Ingenix database of health care provider charges, as well as disease management and financial services units.

They now operate under the brand name Optum, and account for nearly one-third of UnitedHealth’s total business.

In addition, UnitedHealth has been growing its government business since the 2002 acquisition of AmeriChoice, which launched UnitedHealth strongly into the business of managing low-income Medicaid patients. Now, a decade later, WellPoint is doing the same thing with Amerigroup.

The acquisition of PacifiCare greatly expanded UnitedHealth’s presence serving seniors in the Medicare program.

“United has had a decade to make mistakes in businesses,” and WellPoint is just now gaining that expertise, Skolnick said.

Gupte noted that, except for the PacifiCare troubles, smooth integration of acquired companies has become a “core competency” at UnitedHealth that she does not think is matched to the same degree at WellPoint.

UnitedHealth still has weaknesses, not the least of which is its bad reputation with health care providers. In a recent survey of hospitals about contract negotiations, UnitedHealth ranked worst in the industry in four out of six categories. WellPoint ranked lowest in just one.

But since the 2010 passage of President Obama’s health reform law, UnitedHealth has zeroed in on fixing the broken relationship between health insurers and health care providers that was not sustainable for either side.

wellpointIn early 2011, UnitedHealth acquired a 400-doctor practice in California to help bridge the gap between insurers and providers and is developing new financial structures that reward keeping patients healthy, not just doing more tests and procedures.

UnitedHealth separated its suite of wellness, disease management, provider price databases and electronic medical record tools into a separate business unit. Those companies already served numerous outside customers—more than 2,000 health plans, 6,000 hospitals and 240,000 doctors—and are on pace to generate $29 billion in revenue this year.

They also give UnitedHealth a boatload of data that can be fed back to UnitedHealth’s health insurance plans and used to address specific areas where costs are spiking.

“If costs were running high, you could see what employer, what county, what procedure or category was driving this,” wrote Sarah James, a health care analyst at Wedbush Securities in Los Angeles, after a tour through UnitedHealth’s “command center” of data it can provide to employers.

United then created locally targeted interventions based on its data insights to head off large costs.

For example, in one geographic area where the rate of mammograms was significantly below average, James wrote in her Aug. 6 report, UnitedHealth held a health care fair and deployed mobile screening vans that caught three early stage cases of breast cancer.

UnitedHealth seems to be benefiting from its efforts. While both companies have grown their customer rolls in Medicare and Medicaid recently, UnitedHealth has been able to hold its membership steady in its commercial business, too, while WellPoint—which is loathe to squeeze its profit margins to hold onto accounts—has suffered losses.

Controlling costs

WellPoint has not in most cases been able to count on savings from its disease management and wellness efforts to significantly discount its premiums, according to analysts and former WellPoint employees. It has relied instead on its well-known Blue Cross brand name, its broad network of providers and its deep discounts on provider prices.

But WellPoint is running hard to match UnitedHealth on its key strategies for controlling the cost of health care. It has partnered with physician groups in California to create care arrangements that financially rewards doctors for keeping patients healthy and in need of less care.

In addition, WellPoint a year ago bought CareMore Group Inc., which had started its own health plan for Medicare recipients to find ways to make money by cutting off big health problems before they appeared. WellPoint is now replicating that concept at 30 or more locations around the country.

And earlier this year, WellPoint launched an initiative to boost payments to primary care providers in an effort to help them coach patients through chronic diseases before they lead to expensive hospitalizations.

WellPoint’s purchase of Amerigroup will vault it past UnitedHealth as the largest provider of health benefits for low-income Medicaid patients. That program will be expanded by Obama’s health law to cover as many as 16 million additional people.

Vanessa Brown, a human resources consulant at Apex Benefits Group in Indianapolis, said she doesn’t see UnitedHealth offering anything that WellPoint isn’t. Employers change from one insurer to the next frequently, she said, but it’s usually because they find a better fit for their particular needs, not because one is far and away better than the other.

“They both are doing exactly what they need to be right now,” Brown said.

And that’s how Braly sees it, too. While WellPoint has seen some rough patches recently, she is confident the company is making the right moves to re-merge as the preeminent health insurer in the future.

“We believe our decision to maintain pricing discipline and to continue investing in our strong growth opportunities despite difficult market conditions will lay the groundwork for improved performance over time,” she told investors during a July 25 conference call. “We have a strong foundation, brand, and market footprint and expect to deliver greater value to the marketplace in the future.”•

ADVERTISEMENT

  • Classic Case of Greed
    This is a classic case of greed over focused management. The Board of Directors approved Braly's compensation package, and the BOD approved all of the business plans put forth from Braly and her management team. On the surface, it appears that there is more than enough blame to pass around the table.

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. President Obama has referred to the ACA as "Obamacare" any number of times; one thing it is not, if you don't qualify for a subsidy, is "affordable".

  2. One important correction, Indiana does not have an ag-gag law, it was soundly defeated, or at least changed. It was stripped of everything to do with undercover pictures and video on farms. There is NO WAY on earth that ag gag laws will survive a constitutional challenge. None. Period. Also, the reason they are trying to keep you out, isn't so we don't show the blatant abuse like slamming pigs heads into the ground, it's show we don't show you the legal stuf... the anal electroctions, the cutting off of genitals without anesthesia, the tail docking, the cutting off of beaks, the baby male chicks getting thrown alive into a grinder, the deplorable conditions, downed animals, animals sitting in their own excrement, the throat slitting, the bolt guns. It is all deplorable behavior that doesn't belong in a civilized society. The meat, dairy and egg industries are running scared right now, which is why they are trying to pass these ridiculous laws. What a losing battle.

  3. Eating there years ago the food was decent, nothing to write home about. Weird thing was Javier tried to pass off the story the way he ended up in Indy was he took a bus he thought was going to Minneapolis. This seems to be the same story from the founder of Acapulco Joe's. Stopped going as I never really did trust him after that or the quality of what being served.

  4. Indianapolis...the city of cricket, chains, crime and call centers!

  5. "In real life, a farmer wants his livestock as happy and health as possible. Such treatment give the best financial return." I have to disagree. What's in the farmer's best interest is to raise as many animals as possible as quickly as possible as cheaply as possible. There is a reason grass-fed beef is more expensive than corn-fed beef: it costs more to raise. Since consumers often want more food for lower prices, the incentive is for farmers to maximize their production while minimizing their costs. Obviously, having very sick or dead animals does not help the farmer, however, so there is a line somewhere. Where that line is drawn is the question.

ADVERTISEMENT